Dr. Kraemer’s research interests are in the delivery and implementation of patient-centered strategies for the detection and early intervention of unhealthy alcohol and drug use, the application of cost-effectiveness methodology to alcohol and drug detection and treatment programs, and the comparative effectiveness of alcohol and drug addiction treatment on HIV outcomes and quality of HIV care.

He serves as co-investigator and Pittsburgh Principal Investigator for the national, multi-site Veterans Aging Cohort Study (VACS) on the impact of multi-substance use and use in a prospective cohort of 9000 HIV infected and uninfected veterans and a “virtual” cohort of all 47,000+ HIV-infected Veterans in care since 1998. He is currently Principal Investigator of a 5-year NIAAA R01“Comparative Effectiveness of Alcohol and Drug Treatment in HIV-Infected Veterans” which aims to compare the impact of different alcohol and illicit drug treatment approaches on the outcomes of HIV virologic control and quality of HIV care.

Dr. Kraemer has extensive research mentoring experience across the spectrum of predoctoral students to postdoctoral fellows to junior and mid-level faculty. He received his medical degree from the University of California at San Francisco, and his MS from Harvard Medical School, Boston. Dr. Kraemer completed his residency at Oregon Health Sciences University Hospital, Portland, and his fellowship at Harvard Medical School.